Medi&Gene specializes in medical pharmaceutical research and development, providing innovative medicines for chronic metabolic diseases like obesity and type 2 diabetes mellitus.

Vision and Mission: The company is committed to revolutionizing metabolic health solutions with novel, mechanism-of-action-based drug development, aiming to make these solutions sustainable and accessible for all.

Noteworthy Points:

• Founded in 2021 with a focus on curing sarcopenic obesity and diabetes.
• Holds patents for pharmaceutical compositions treating fatty liver disease and novel peptides.
• Backed by prominent investors including Korea Investment Partners and Korea University Holdings.